Posted in the category:

Neurodegeneration

Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders

Posted on January 22, 2021

Eric J Lenze, Ginger E Nicol, Dennis L Barbour, […] Thomas L Rodebaugh. J Psychiatry Neurosci 2021;46(1):E97-E110 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer’s disease

Posted on January 21, 2021

Carla M Yuede, […], John R Cirrito. J Neurochemistry. 2020 Dec 5 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Evaluating cognitive relationships with resting-state and task-driven blood oxygen level-dependent variability

Posted on January 21, 2021

Peter R Millar, Beau M Ances, Brian A Gordon, Tammie L S Benzinger, John C Morris, David A Balota. Journal of Cognitive Neuroscience, Volume 33 | Issue 2 | February 2021 p.279-302 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: , , ,

Flortaucipir (tau) PET in LGI1 antibody encephalitis

Posted on January 21, 2021

Gregory S Day, Brian A Gordon, Austin McCullough, Robert C Bucelli, Richard J Perrin, Tammie L S Benzinger, Beau M Ances. Annals of Clinical and Translational Neurology 2021 Jan 7. Read More

Posted in: HPAN, Neurodegeneration Faculty: , , ,

Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy

Posted on January 11, 2021

Ursula Moore, […] Alan Pestronk, Maggie C. Walter, Carmen Paradas, Tanya Stojkovic, Madoka Mori-Yoshimura, Elena Bravver, Elena Pegoraro, Jerry R. Mendell, on behalf of The Jain COS Consortium, Kate Bushby, Volker Straub1 and Jordi Diaz-Manera. Frontiers in Neurology, Volume 11, 16 December 2020, Article number 613446 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: